On May 11, 2026, QIT held a signing ceremony for Industry-University-Research cooperation with Shandong Sibond Pharmaceutical Trading Co., Ltd. (hereinafter referred to as “Sibond Company”). Shan Chengjuan, Vice President of QIT; Liu Peng, Assistant to the Chairman of Sibond Company; Wang Jicheng, Marketing Director of Sibond Company; and relevant officials from the School of Medicine attended the event.